Back

Interleukin-6 rs1800796 G/C polymorphism is associated with poor clinical outcomes in patients with coronary artery disease

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (4) - Innovations in cardiovascular repair: immune, genetic, and therapeutic perspectives Leukocytes, Inflammation, Immunity ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jiawen Li

Beijing (China)

10 More presentations in this session

Presentation thumbnail
Discussant - Innovations in cardiovascular repair: immune, genetic, and therapeutic perspectives
Presentation thumbnail
DAMPs exacerbate post-myocardial infarction cardiac injury via suppression of AP-1 signaling: critical role of impaired lymphatic endothelial cell proliferation
Doctor S. Li (Nanjing, CN)
Abstract Slides Video
Presentation thumbnail
Effects of liraglutide on progenitor cell lineage and maturation in cd34+ hematopoietic stem cells: a single-cell rna sequencing analysis
Doctor G. Damiano (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Functional screenings on a multicellular level identifies pro-proliferative miRNAs in human iPSC-derived cardiomyocytes with potential synergistic effects for heart repair
Doctor Y. Gong (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Endothelial glycocalyx integrity of the sublingual microvessels as a predictor of left ventricular performance following STEMI: a 12-month study
Doctor K. Katogiannis (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (4) - Innovations in cardiovascular repair: immune, genetic, and therapeutic perspectives

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Association of interleukin gene polymorphisms with coronary artery disease severity
thumbnail
Congress Presentation
Interleukin 1B gene polymorphism is associated with poor clinical outcomes in patients with coronary artery disease
thumbnail
Congress Presentation
Interleukin 6 in asymptomatic patients with nonsevere aortic valve stenosis: a post-hoc study of the SEAS trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources